| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |